Fifth Third Bancorp cut its stake in shares of Genpact Limited (NYSE:G – Free Report) by 7.9% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 3,188 shares of the business services provider’s stock after selling 273 shares during the quarter. Fifth Third Bancorp’s holdings in Genpact were worth $140,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Sumitomo Mitsui Trust Group Inc. purchased a new stake in shares of Genpact in the first quarter valued at approximately $115,807,000. Clark Capital Management Group Inc. purchased a new position in Genpact in the 1st quarter worth $64,842,000. Ameriprise Financial Inc. grew its position in Genpact by 109.8% during the 1st quarter. Ameriprise Financial Inc. now owns 1,615,220 shares of the business services provider’s stock worth $81,375,000 after purchasing an additional 845,393 shares during the period. JPMorgan Chase & Co. grew its position in Genpact by 20.9% during the 1st quarter. JPMorgan Chase & Co. now owns 4,111,340 shares of the business services provider’s stock worth $207,129,000 after purchasing an additional 710,704 shares during the period. Finally, Price T Rowe Associates Inc. MD grew its position in shares of Genpact by 421.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 767,386 shares of the business services provider’s stock valued at $38,662,000 after acquiring an additional 620,201 shares during the period. 96.03% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
Several equities research analysts recently issued reports on the company. Deutsche Bank Aktiengesellschaft began coverage on Genpact in a report on Thursday, July 17th. They issued a “hold” rating and a $47.00 price objective on the stock. Mizuho boosted their price target on shares of Genpact from $48.00 to $51.00 and gave the stock a “neutral” rating in a research note on Tuesday, July 1st. Wall Street Zen downgraded shares of Genpact from a “buy” rating to a “hold” rating in a research note on Friday, September 5th. Needham & Company LLC boosted their price target on shares of Genpact from $50.00 to $53.00 and gave the company a “buy” rating in a research report on Friday, August 8th. Finally, JPMorgan Chase & Co. decreased their target price on shares of Genpact from $55.00 to $50.00 and set a “neutral” rating for the company in a research note on Wednesday, August 20th. Three research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $52.29.
Genpact Trading Down 0.0%
G opened at $41.87 on Thursday. The stock has a market capitalization of $7.30 billion, a PE ratio of 13.91, a PEG ratio of 1.44 and a beta of 0.89. The company has a current ratio of 1.53, a quick ratio of 1.53 and a debt-to-equity ratio of 0.32. Genpact Limited has a 1-year low of $37.82 and a 1-year high of $56.76. The firm has a 50-day moving average price of $43.52 and a two-hundred day moving average price of $45.06.
Genpact (NYSE:G – Get Free Report) last issued its earnings results on Thursday, August 7th. The business services provider reported $0.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.85 by $0.03. Genpact had a net margin of 10.92% and a return on equity of 22.15%. The company had revenue of $1.25 billion for the quarter, compared to analyst estimates of $1.23 billion. During the same quarter last year, the firm earned $0.79 EPS. The company’s revenue for the quarter was up 6.6% on a year-over-year basis. Genpact has set its FY 2025 guidance at 3.510-3.580 EPS. Q3 2025 guidance at 0.890-0.900 EPS. As a group, equities analysts anticipate that Genpact Limited will post 3.21 earnings per share for the current fiscal year.
Genpact Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Thursday, September 11th were issued a $0.17 dividend. The ex-dividend date was Thursday, September 11th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.6%. Genpact’s dividend payout ratio (DPR) is 22.59%.
Insiders Place Their Bets
In other Genpact news, CEO Balkrishan Kalra sold 55,000 shares of Genpact stock in a transaction on Thursday, September 11th. The shares were sold at an average price of $43.36, for a total transaction of $2,384,800.00. Following the completion of the transaction, the chief executive officer directly owned 295,246 shares of the company’s stock, valued at $12,801,866.56. The trade was a 15.70% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Piyush Mehta sold 76,902 shares of the business’s stock in a transaction dated Friday, September 12th. The shares were sold at an average price of $42.58, for a total transaction of $3,274,487.16. Following the completion of the sale, the senior vice president directly owned 134,880 shares of the company’s stock, valued at approximately $5,743,190.40. The trade was a 36.31% decrease in their position. The disclosure for this sale can be found here. 3.07% of the stock is currently owned by insiders.
Genpact Company Profile
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Further Reading
- Five stocks we like better than Genpact
- How to Invest in Blue Chip Stocks
- Datavault AI: The New AI Contender Backed by Big Funding
- What Are the U.K. Market Holidays? How to Invest and Trade
- CoreWeave: Why the New King of AI Infrastructure Has Room to Run
- Insider Trades May Not Tell You What You Think
- Top 3 Dividend Achievers for October: High Yields, Growth Ahead
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.